Congenital heart disease (CHD) is the most common birth defect with an incidence of 1%.
of the anatomic features along with common interventions and their sequelae is central to caring for patients with CHD. CHD lesions and their defining anatomic features are summarized in Table 1 along with common surgical interventions and residual defects to be assessed at the time of imaging. The imaging modality of choice is determined by findings on history and physical examination. TTE is reliable in diagnosing most CHD in the pediatric and adult populations. 4, 5 Additional imaging is required if the goals of imaging are not achieved with echocardiography or guidelines recommend cross-sectional imaging (as for patients with aortopathy at high risk of aortic dissection). 6 Noninvasive imaging options include cardiac magnetic resonance (CMR) imaging, cardiac computed tomography (CT), and nuclear scintigraphy. Cardiac catheterization remains the gold standard for direct hemodynamic assessment. A guide to imaging modalities in CHD is provided in Figure 1 . Technical considerations and the relative strength of each imaging modality for quantifying ventricular volumes and function are summarized in Table 2 . Imaging guidelines for CHD are available, and the reader is referred to publications from the American Society of Echocardiography, [7] [8] [9] [10] the Society for Cardiovascular Magnetic Resonance, 11 and the Society of Cardiovascular Computed Tomography. 12, 13 Frequency of cardiac imaging varies by CHD subgroup, patient age, clinical status, surgical palliation, other cardiac interventions, and residual hemodynamic anatomic defects. Adults with shunt lesions deemed not to be of hemodynamic significance may have an echocardiogram every 3 to 5 years. 3 By contrast tetralogy of Fallot (TOF), patients are recommended to undergo echocardiography every 12 months until the age of 10 years and then 24 months thereafter. 10 More frequent imaging should be considered in patients with heart failure, pulmonary hypertension or higher-risk lesions such as single ventricle physiology, and moderate-to-severe valvular dysfunction.
Echocardiography
Two-dimensional (2D) imaging of anatomic structures combined with Doppler techniques (color, pulsed, and continuous wave) and contrast enables CHD to be diagnosed with a high degree of accuracy.
14 For serial surveillance, TTE is widely available, inexpensive, portable, and not associated with ionizing radiation. These factors combined with a significant body of research and clinicians' familiarity have resulted in TTE being the first-line imaging modality of choice in CHD.
Geometric Techniques
Geometric techniques include linear measurements with M-Mode and volumetric measurements obtained by 2D echocardiography. Both techniques are load sensitive and rely on geometric assumptions. As such, they do not readily apply to many patients with CHD, particularly those with geometrically complex hearts and significant pressure or volume overload. Simpson biplane ejection fraction (EF) remains an important measure of left ventricular (LV) function in patients with CHD after biventricular repair and in those with left-sided disease.
The right ventricle (RV) is uniquely at risk in CHD because of the high prevalence of right-sided lesions. This includes right-sided obstructive lesions (TOF with residual RV outflow tract obstruction and pulmonary atresia), volume overload lesions (TOF with residual pulmonary regurgitation and Ebstein malformation with tricuspid regurgitation), patients with a systemic RV (l-TGA transposition of the great arteries [TGA]/congenitally corrected TGA and d-TGA after atrial switch, hypoplastic left heart syndrome post Fontan) and pulmonary hypertension complicating CHD. Assessment of RV size and function is, therefore, a major focus of imaging in CHD. The anatomy and complex geometry of the RV mean that Simpson biplane EF is not a reliable measure of RV systolic function. Fractional area change (FAC) calculated from the apical 4-chamber is an alternative 2D measure of RV function that is made by subtracting the end-systolic area from the end-diastolic area and dividing the difference by the end-diastolic area. An FAC of <40% signifies reduced RV systolic function 15 and correlates with CMR-derived EF in pulmonary hypertension and heart failure. 16 In patients with complex CHD, FAC is less accurate because it does not account for regional remodeling and dysfunction as seen in TOF patients with akinetic and aneurysmal RV outflow tracts. FAC has been shown to overestimate RVEF in TOF patients and is, therefore, not recommended as a sole measure of RV systolic function. 10 By correcting for geometric distortions, 3D echo overcomes the limitations of the biplane Simpson, area-length, and FAC methods ( Figure 2 ). Compared to 2D measures, ventricular volumes obtained by 3D echocardiogram correlate more highly with CMR. 17, 18 Three-dimensional echo provides important anatomic information before surgery in patients with atrioventricular septal defects, 19 aortic valve disease, 20 and RV outflow tract abnormalities. 21 In adults with CHD, 3D echocardiography is often more challenging because of limited acoustic windows, poor endocardial border detection, and low frame rate. Three-dimensional echo has also been shown to underestimate ventricular volumes in CHD compared with CMR. 17, 21, 22 Three-dimensional knowledge-based reconstruction (3DKBP) is a more novel approach to assess RV volumes in CHD. This technique uses 2D data points which are transmitted to an online database and compared with a lesion-specific catalog to derive reconstruction of the RV. Early experiences with 3D knowledge-based reconstruction in children and adults with TOF 23 and RV to pulmonary artery conduits 24 indicate high agreement with magnetic resonance imaging (MRI). 25 Further studies are needed before 3D knowledge-based reconstruction can be recommended for clinical practice. 31 and tricuspid annular plane systolic excursion (TAPSE). 32 These measures are attractive in CHD because uniform ventricular geometry is not essential. Four measures (TDI, Strain, IVA, and TAPSE) will be discussed in this review selected by ease of measurement, reproducibility, published normative data, and research impact to date.
TDI in either pulsed-wave or color modes measures the velocity of the longitudinal motion of the mitral and tricuspid annulus as surrogates for ventricular contraction and relaxation. 33, 34 Normative values have been published for children and adults. 35, 36 TDI is angle dependent, and parallel alignment of the ultrasound beam to the vector of myocardial motion is essential. TDI is also sensitive to ventricular preload and 38 Importantly, TDI does not discriminate passive motion (due to cardiac translation or tethering) from active motion (fiber shortening or lengthening). This is relevant in patients with regional myocardial dysfunction after CHD repair. A linear correlation between TDI-and CMR-derived RVEF has been reported in adults with and without CHD, 39 although the strength of correlation is diminished as CHD becomes more complex as seen in patients with TOF, 40 Fontan 41 and Ebstein anomaly. 42 On the basis of these data, TDI is not recommended as a sole clinical measure of global ventricular function in CHD.
Strain and strain rate imaging by color-coded tissue Doppler or 2D speckle-tracking measures the degree of myocardial shortening or lengthening (both longitudinally or circumferentially), or thickening and thinning (in the radial direction). Strain is expressed as the percentage change in length from the original length. Strain rate is the rate of deformation (per second). These techniques rely on automated tracking of myocardial deformation in defined ventricular segments that can also be summed to determine global longitudinal strain (GLS). Global circumferential and radial strain may also be assessed but have less received less attention in CHD research undertaken to date. The accuracy of strain analysis depends on good 2D image quality. Normal values for strain and strain rate have been published for neonates, 43 children, 44 and adults. 30 Strain measurements vary considerably according to the ultrasound machine and software platform being used. 45 The same ultrasound machine and software must, therefore, be used when tracking serial measures for comparison. 46 Identifying reduced GLS in the presence of CHD 46-49 may aid risk stratification. GLS reduction in adults with d-transposition of the great arteries and previous atrial switch is associated with elevated N-terminal pro-B-type natriuretic peptide, heart failure progression, and arrhythmia. 47, 48, 50 In children with repaired TOF, an RV GLS cutoff of −18% had good sensitivity and specificity (78% and 77%, respectively) for identifying RVEF <45% by CMR. 51 In patients with congenitally corrected transposition of the great arteries, a GLS cutoff ≤16.3% identified CMRderived systemic RVEF ≤45% with a sensitivity of 77% and specificity of 73%. 53 IVA has been used in CHD research as a measure of ventricular force frequency relationship and reflects the fundamental ability of the myocardium to alter contractile force with changes in heart rate. Abnormal ventricular force frequency relationships have been reported in CHD including after TOF repair, 54, 55 after atrial switch repair of d-transposition of the great arteries, 56 and in patients with single ventricle physiology. 57 Significantly reduced IVA values have also been reported in children seen after aortic coarctation stenting, indicating myocardial contractile reserve is impaired even in the presence of normal EF. 58 The long term clinical implications of these findings have not been assessed.
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TAPSE is easily obtainable and reflects longitudinal myocardial shortening, the main component of RV contraction. TAPSE is measured using 2D echocardiography in the 4-chamber view with the M-mode cursor placed through the lateral right ventricular annulus in real time. Reference values have been published for children and adults. 8, 59 TAPSE is a developmentally dependent variable that increases from infancy to adolescence. 60 65 correlations between TAPSE-and CMR-derived values were, however, poor. To date, no studies have evaluated TAPSE as a predictor of adverse clinical outcomes, although the finding that TAPSE declines in parallel with RV systolic function supports a role for serial tracking of TAPSE in patients with TOF. 60 Examples of ventricular quantitation using GLS (Figure 3) , TDI, IVA, and TAPSE (Figure 4 ) are provided.
Stress Echocardiography
Stress echocardiography has widespread clinical application in CHD. The two most commonly used methods are exercise or pharmacological stress with dobutamine combined with echocardiography. Clinical indications include screening for coronary ischemia, evaluating the severity of subaortic stenosis, screening for aortic coarctation/recoarctation, and assessing congenital aortic valve stenosis severity in the presence of low EF. The choice of exercise versus dobutamine stress depends on patients' ability to exercise and the clinical indication for the test including the need for understanding the relationship between physical exertion, symptoms, ventricular, and valvular function. Patients with CHD have a higher prevalence of musculoskeletal and developmental abnormalities that may limit their ability to exercise. Dobutamine, a β-agonist, can be safely used in most patients. There is an increased risk of supraventricular arrhythmia and nonsustained ventricular tachycardia with dobutamine, although these are usually short lived and rarely require treatment.
Symptomatic patients with subaortic stenosis with peak gradients less than 50 mm Hg are recommended to undergo exercise echocardiography to determine whether gradients increase with exertion. In aortic coarctation, demonstration of turbulent flow in the proximal descending aorta, forward diastolic flow, and a significant (>20 mm Hg) continuous wave Doppler coarctation gradient at rest or after exercise is an indication for further investigation which may include cardiac catheterization. 3 Stress echocardiography should also be considered in patients with a history of systemic to pulmonary artery shunts and unexplained exercise intolerance or dyspnea. In these patients, stress echocardiography can unmask early pulmonary vascular disease seen as an abnormally steep increase in pulmonary pressure after exercise.
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Shunt Quantification
Echocardiography for shunt quantification is achieved by measuring the pulmonary:systemic flow ratio, Qp:Qs. In the anatomically normal heart, left-and right-sided stroke volumes are practically equal. In patients with significant left to right shunting, pulmonary stroke volume exceeds systemic blood flow such that the Qp:Qs ratio is increased. A Qp:Qs ratio of > 1.5:1.0 is significant, particularly in the presence of ventricular volume overload or dysfunction. 3 High correlation has been reported between echocardiographic versus cardiac catheterization-derived Qp:Qs ratio, 67 although accuracy is heavily dependent on the sampling site and cross-sectional area measurement. 68 Attention must be paid to the pulmonary and LV outflow tract diameters because small errors in these measures leads to significant under or overestimation of cross-sectional area (and therefore Qp:Qs quantitation). Compared to echocardiography, CMR makes fewer assumptions and is now regarded as the most accurate noninvasive technique for shunt quantification in CHD. In patients where pulmonary vascular resistance and reversibility needs to be assessed or where direct invasive hemodynamics is indicated, cardiac catheterization remains the gold standard.
Cardiac MRI
In fulfillment of early visions of CMR as a method for both structural and biochemical cardiac assessment, 69 contemporary scanners offer a comprehensive, multiplane evaluation of cardiac morphology and performance making it, especially, relevant to ACHD. The use of CMR includes assessment of valves, baffles, conduits, great vessels and their branches, veins, and the myocardium itself. 
E velocity (early diastolic motion), and A velocity (atrial contraction). B,
Measuring isovolumic acceleration (IVA) during isovolumic contraction at the basal segment of the right ventricular free wall. IVA is the ratio between the maximum isovolumic velocity (IVV) and time to maximal isovolumic velocity (t). C,Tricuspid annular plane systolic excursion (TAPSE) is measured using 2-dimensional echocardiography in the 4-chamber view with the M-mode cursor placed through the lateral annulus.
Standard CMR Applications in CMR
The steady-state free precession sequence is the predominant tool used in CMR. It captures cardiac motion in cine formats with easy differentiation of myocardium from blood pool. Contrast administration is not required. Each frame is generated from data acquired over many beats, so quality imaging can be achieved even in tachycardia (ie, in children). Complete scans can be acquired within one breath hold of 10 to 15 seconds. With its combination of spatial and temporal resolution, steady-state free precession specifically is applied for the quantification of ventricular mass, volume, and EF. Measurements are done on a contiguous stack of short-axis steady-state free precession cine sequences and require no assumptions about the uniformity of ventricular geometry and can be applied to even the most complex ventricular anatomy. For this reason, CMR is now considered the reference standard in CHD for RV volume quantification, RV outflow tract obstruction, pulmonary valve function, venous assessment, or assessment of the great arteries. 70 "Black blood" imaging refers to spin echo imaging techniques involving an excitation and refocusing pulse. Protons that move through the imaging plane, such as moving blood, will not generate a signal on the image because the affected protons "wash out" after the initial excitation pulse. These techniques are generally longer acquisitions and allow for only a single phase of imaging in each cardiac cycle per breath hold. Thus, they are used for tissue characterization, such as identification of myocardial edema or fat. Black-blood still-image techniques differentiate features such as aortic wall abnormalities or small shunts. Overcoming the major technical limitations of echocardiography, morphology and function can be assessed independent of body habitus. Furthermore, probe positioning and beam alignment-both critical for Doppler techniques in echocardiography-are no longer an issue with CMR. The main limitation of CMR is the need for reliable breath holding to minimize diaphragm motion, and this may limit the use in pediatric populations or in patients with other disabilities that limit breath hold time.
CMR has played a central role in demonstrating the importance of progressive ventricular dilation and dysfunction in various forms of CHD, including TOF, [72] [73] [74] in Mustard/ Senning patients, 75 and in adults with a Fontan circulation. 76 Demonstrating reverse remodeling is less likely to occur once RV end-diastolic volume indexed is >150 to 170 mL/m 2 , CMR imaging has been important for establishing thresholds for pulmonary valve replacement in TOF. CMR has also been used in Fontan patients to show ventricular dilation as being associated with increased risk. Among 215 young adults with a Fontan circulation (median age 18 years), ventricular dilation (ventricular end-diastolic volume >125 mL/body surface area 
Two-Dimensional Phase Contrast Imaging
Phase contrast imaging is important when imaging patients with CHD. 77 This technique involves acquiring a short-axis plane of a vessel to capture a pixel map of velocity. By defining a region of interest along the vessel wall through each phase of the cardiac cycle, it is possible to calculate flow as the product of mean velocity and area. Forward and reverse flow is then quantified leading to measures commonly used for clinical decision making in CHD; aortic/pulmonary valve regurgitant fraction, differential pulmonary artery flow for evaluation of pulmonary artery stenoses, and collateral flow in aortic coarctation and Fontan patients. 78 Jet direction and speed may be assessed using within plane flow. Because of its ability to quantify ventricular volumes and flow, CMR is now the reference standard for pulmonary regurgitation. In contrast to CMR, 2D echocardiography has a limited ability to quantify pulmonary regurgitation and RV function. Phase contrast velocity mapping with a flow-sensitive gradient-echo sequence is performed in the main pulmonary artery to assess the regurgitation fraction. Pulmonary regurgitation is graded as mild if the regurgitation fraction is <20%, moderate if between 20% and 40%, and severe if >40%. Unlike echocardiography where sonographers search in real time to identify the maximum regurgitant jet, CMR has prespecified views based on optimal imaging planes, and regurgitation severity may, therefore, be underestimated. Shunt quantification is achieved in 2 ways; either by comparison of stroke volumes or aortic and pulmonary blood flow by phase mapping. Although there is inherent variability in these quantifications, 79 CMR makes fewer assumptions than echocardiography in shunt quantification and may be considered more accurate. CMR is not able to measure pulmonary artery pressure, however, prediction equations for pulmonary vascular resistance have been proposed based on flow, ventricular mass, and septal curvature. 
Three-Dimensional Slab Imaging
Three-dimensional "slab" imaging, where any segment of the chest is assessed with thinner, static images, with or without contrast enhancement, are useful for anatomic clarification and off-line reconstruction much like computed tomography. These thinner slices allow visualization of smaller blood vessels such as collateral arteries, aortopulmonary collaterals in pulmonary atresia, venovenous collaterals or atriovenous fistulae after Fontan palliation, or defining the course of an anomalous coronary artery. The ability for off-line reconstruction and maximal intensity projection allows for 3D reconstruction of anatomically complex relationships ( Figure 5 ).
Fibrosis Imaging
CMR studies using late gadolinium enhancement (LGE) have revealed important associations between fibrosis, electromechanical disturbance, ventricular dysfunction, and adverse clinical outcomes in CHD. [81] [82] [83] [84] [85] [86] Imaging 5 to 20 minutes after contrast injection allows for assessment of LGE (or delayed enhancement).
LGE has been shown to be highly sensitive for detecting focal areas of fibrosis in many forms of CHD, including TOF, 82, 87 transposition of the great arteries, 83 and single ventricle/Fontan palliation. 86 LGE has been associated with poorer functional class, arrhythmia or lower exercise capacity. Fibrosis needs to be interpreted with knowledge of the patient's previous surgery to identify scar sites or patches. Whether the presence of late enhancement can or should dictate a different management strategy for the patient is unknown.
LGE is less reliable for diffuse fibrosis which is often the norm in CHD. 84 Extracellular volume (ECV) fraction via T1 mapping is an emerging technique for quantifying diffuse myocardial fibrosis and correlates with quantitative histopathology. 88 It has been used to demonstrate diffuse LV fibrosis in congenital aortic stenosis, 89 the pressure-loaded systemic RV, 90 and in patients with TOF. 85 Elevated ECV fraction in adults with TOF is associated with diffuse LV myocardial fibrosis and adverse clinical parameters, including longer QRS duration, reduced 6-minute walk distance, higher B-type natriuretic peptide, and increased atrial volumes. 85 Arrhythmia and cardiovascular death are also more common in tetralogy patients with elevated ECV, even in the presence of preserved systolic function. ECV patterns in the RV have been shown to vary substantially with different loading conditions. 91 ECV has also been shown to correlate with bypass and cross-clamp times during surgical repair. 92 With these emerging studies, ECV seems to be a promising prognostic index in CHD.
Four-Dimensional Flow
Four-dimensional magnetic resonance velocity mapping (4D Flow) encodes flow in three directions over time within a 3D volume set, thus enabling omni-directional visualization and quantification of blood flow in multiple vessels. 93 4D Flow has been used to show systolic helical flow in the descending aorta after coarctation repair, which is relevant for understanding the pathophysiology of systemic hypertension and vascular remodeling. 94 It has also been used to characterize patterns of aortopathy related to altered shear stress in the setting of a bicuspid aortic valve. 95 In Fontan patients, 4D Flow has been used to quantify the distribution of caval blood flow to the pulmonary circulation, providing new insights into the relationship between flow distribution and Fontan vessel geometry, 96 as well as unique ventriculo-valvular interactions from a single ventricle. 97 These methods require dedicated analysis software and time for computation, decreasing their value as clinical tools, although they will undoubtedly provide further insights in ventriculo-arterial coupling that may shape clinical thinking in the future.
Stress CMR
Another well-established application of CMR is first pass perfusion imaging with stress. Various techniques have been studied extensively in acquired heart disease. 98 In CHD, although not used as often, its use is found in the assessment of anomalous coronary arteries or those with previous coronary ostial reimplantation (arterial switch operation or Ross procedure) with generally good correlation with other coronary imaging or clinical findings. 99 Three agents are available for use in vasodilator stress CMR: adenosine, dipyridamole, and regadenoson. Dipyridamole is the cheapest but has the longest half-life (40 minutes) and requires reversal with a bolus of Figure 5 . Three-dimensional (3D) imaging of extracardiac Fontan pathway. Three-dimensional reconstruction of an extracardiac Fontan pathway using cardiac magnetic resonance 3D slab imaging. LPA indicates left pulmonary artery; RPA, right pulmonary artery; and SVC, superior vena cava.
aminophylline to prevent delayed side effects. Adenosine is a breakdown product of dipyridamole with a short half-life of around 10 s. This makes it safe to use because any untoward pharmacological effects, including high grade heart block, may be reversed rapidly by stopping the drug infusion. The principal disadvantage relates to the need to give it as an infusion rather than a bolus because of its short half-life. This necessitates placement of a second intravenous line for the administration of the gadolinium bolus during peak stress. Both dipyridamole and adenosine act nonselectively on adenosine receptors that may trigger bronchospasm in susceptible patients. Regadenoson avoids this problem by selective stimulation of only A2a receptors. Regadenoson is given as a slow intravenous push over 15 or so seconds. Maximum coronary vasodilation is achieved by 1 to 2 minutes. All 3 drugs are competitively inhibited by methylxanthines, and therefore ingestion of caffeinated substances (including so-called decaffeinated beverages) is contraindicated for at least 12 hours before stress in most laboratories.
Safety Considerations With CMR
Many patients with CHD have implanted cardioverter-defibrillators or pacemakers, historically viewed as contraindications. It is now clear that most are not adversely affected by scanning at 1.5 Tesla, nor is patient safety seriously jeopardized. 100, 101 Protocols for safely imaging those with implanted devices have been developed. 102 Patients with abandoned pacemaker leads or epicardial systems are still excluded. Signal loss artifacts from the generator or leads can limit interpretability of the scan, particularly of the areas closest to the generator. In patients with pacemakers the image quality can be excellent, although artifacts tend to be greater from implanted cardioverter-defibrillators. Many patients with CHD have stents in pulmonary arteries or aorta, including recipients of Melody valves in pulmonary position or coarctation stents, or coil occluders of unwanted collaterals. Although not harmful in an MRI environment, abundant artifacts from these metals can significantly obscure areas of interest. Sternotomy wires, stents, and prosthetic valves usually do not create a problem with imaging except within their immediate vicinity.
Claustrophobia affects roughly 5% of the population. Open bore scanners and anxiolytic medications may help, but for an ideal scan patients should remain awake to comply with breath-hold instructions. Rarely, if ever, is general anesthesia warranted for a study. Pregnancy is not a contraindication to CMR. 103 Gadolinium-based contrast is thought to be safe 104 but is usually avoided in pregnancy. Recently, concerns about somatic gadolinium retention were prompted by the finding of differences in T1 times in portions of the brain long after gadolinium administration. 105 and residual gadolinium on autopsy studies. 106 Studies demonstrating gadolinium retention in the brain have not demonstrated clear neurological deficits related to these findings. Nephrogenic systemic fibrosis, a condition believed to be related to gadolinium deposition in the skin in the setting of renal dysfunction, has prompted concerns about gadolinium contrast use in those with renal dysfunction. However, gadolinium is not known to harm the kidneys directly, unlike other radiopaque contrast agents. CMR contrast agent selection should be informed by these findings.
Cardiac CT
Cardiac CT has grown rapidly in importance in CHD over the past decade. Ready availability, short acquisition times, and the ability to create 3D volumes of complex anatomy have led to cardiac CT playing a central role in imaging of CHD. Current generation multidetector CT scanners with rapid gantry rotation provide high spatial resolution combined with temporal resolution as low as 66 ms. Full acquisition of the cardiac anatomy is complete after only a portion of the cardiac cycle or within seconds making CT, especially useful in the pediatric populations and adults who are unable to lay flat or breath hold for extended time periods. Although CMR remains the gold standard for evaluating cardiac anatomy and function in CHD, cardiac CT is a useful alternative when further information is needed or in the presence of contraindications to CMR. 70 Common applications of cardiac CT in CHD include coronary evaluation, anatomic assessment, and exclusion of complications, such as intracardiac thrombus, baffle obstruction, 108 and prosthetic valve dysfunction. 109, 110 ECG gating is used to improve temporal resolution and minimize artifacts caused by cardiac motion. Because of its ability to enable more precise assessment of smaller anatomic structures, ECG gating is essential for coronary CT angiography, pulmonary venous abnormalities, and the thoracic aorta and its branches. Cardiac catheterization remains the gold standard for visualizing the entire coronary system and for the diagnosis/ exclusion of coronary artery disease. However, cardiac CT is increasingly being used as a noninvasive alternative for coronary evaluation in CHD. 12, 13, 111 This includes patients with anomalous coronaries, 112, 113 patients at risk of ostial stenosis after coronary reimplantation procedures (Ross, Bentall, and Jatene), and for exclusion of atherosclerosis in patients with ischemic symptoms or before cardiac surgery. For anomalous coronary disease, cardiac CT enables assessment of several anatomic and prognostic features, including coronary ostial narrowing, acute angulation, and an interarterial course. [114] [115] [116] Understanding coronary relationships to surrounding structures is also important before percutaneous pulmonary valve implantation because stent expansion can lead to coronary compression and ischemia ( Figure 6 ). Coronary imaging is best performed at heart rates <60 bpm to maximize image quality. Lower heart rates can be achieved safely in children with β-blockers, 117 although caution is required in patients with conduction disease and heart failure. Common uses of cardiac CT in specialist CHD centers are summarized in Table 3 .
Limitations of cardiac CT include inability to quantify valve regurgitation, poor myocardial tissue characterization, and exposure to ionizing radiation and contrast. Multidetector CT scanners have been shown to be comparable to CMR for the quantification of LVEF. 118 However, cardiac CT is not commonly used for serial assessment of ventricular function because of cumulative radiation exposure and cancer risk. At present, cardiac CT plays a limited role in tissue characterization and ECV characterization for subclinical fibrosis. 12 More recent developments in the field of cardiac CT include vasodilator stress perfusion, 119 dobutamine stress CT, 120 and coronary physiology modelling using computational fluid dynamics to predict functional significance of lesions.
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Safety Considerations With CT
Despite the reported low radiation exposure from a single scan, congenital patients require lifelong care, and cumulative radiation is not insignificant. 122 Because of the cancer risks associated with cumulative radiation, alternative imaging modalities (echocardiography and CMR) are recommended for serial quantification. Contrast exposure with CT is another important safety consideration in patients with CHD. Typical cardiac CT studies require 1 to 2 mL/kg of contrast volume and carry low rates of adverse complications ranging from 0.1% to 1%. 123 Nephrotoxicity is, especially, important in patients with preexisting renal dysfunction, heart failure receiving high-dose diuretics, and those receiving high contrast loads (ie, patients undergoing both cardiac CT and cardiac catheterization).
Extracardiac Imaging
Over one-third of hospital admissions for adult patients with CHD are for non-cardiovascular reasons. 124 Awareness of extracardiac manifestations of CHD is, therefore, essential when caring for these patients. An exhaustive list of extracardiac disease in CHD is beyond the scope of this review. Highlighted are extracardiac abnormalities of increasing clinical significance in CHD.
Brain
The prevalence of cerebrovascular accidents is increased in CHD, the highest incidence being in cyanotic heart disease and left-sided lesions. 125 In addition to stroke, patients with CHD have an increased prevalence of structural brain abnormalities. In one series of adolescents with CHD, 66% had some abnormality on brain MRI (MRI), with 13% having evidence of a stroke. 126 Using magnetic resonance angiography and CT angiography, intracranial aneurysms have been demonstrated in 10% of adults with coarctation of the aorta. 127 Brain MRI often provides the best assessment of cerebrovascular disease and structural abnormalities in CHD. CT may be considered in emergent situations and in patients with contraindications to MRI.
Lung Disease
Lung mechanics are impaired and commonly restrictive in 44% to 47% of adult patients with CHD. 128 Restrictive lung disease may be seen with lung underdevelopment, such as in Scimitar syndrome with right lung hypoplasia or in congenital pulmonary stenosis and TOF with reduced pulmonary blood flow. Pneumonia is increasingly documented as a cause of mortality in complex CHD. 129 Chest x-ray is the ideal first-line Exclusion of intracardiac thrombus prior to cardioversion † Simultaneous evaluation of lung parenchymal pathology and extracardiac structures CHD indicates congenital heart disease; CMR, cardiac magnetic resonance; CT, computed tomography; and RV, right ventricle.
*Magnetic resonance imaging safety protocols differ between centers. Local consultation is recommended in CHD patients with potential contraindications to CMR.
†CT may be considered for exclusion of intracardiac thrombus in emergent or unstable patients and those with contraindications to transesophageal echocardiogram.
imaging modality for lung disease in CHD, although high-resolution CT is essential for diagnosis and exclusion of thromboembolic disease in patients with pulmonary hypertension.
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Liver Disease
Fontan-associated liver disease is an important precursor to adverse outcomes in Fontan patients, including hepatocellular carcinoma. 131, 132 Systemic venous hypertension and reduced cardiac output lead to hepatic congestion, hepatocyte atrophy, sinusoidal fibrosis, perivenular and peri-portal fibrosis, and ultimately cardiac cirrhosis. 133 Multi-modality imaging is commonly used to assess the liver in patients with CHD starting with a screening abdominal liver ultrasound. Additional testing may include triple-phase CT or CMR. Multi-phase contrast enhancement in the venous, arterial, portal venous, and later phases allow for visualization of liver parenchyma, congestion, fibrosis, and hypervascular nodules. Hepatocellular carcinoma has a characteristic appearance with rapid washout becoming hypo-intense relative to the surrounding parenchyma in the later phases. Flurodeoxyglucose-positron emission tomography may be useful for localizing hepatocellular carcinoma (Figure 7) . Because of the high burden of liver disease, surveillance should start early (10-12 years of age) initially with ultrasound scans then alternating with MRI and CT to minimize radiation. CMR or ultrasoundbased elastography is a promising noninvasive technique that has been shown to correlate with liver stiffness and fibrosis. 134, 135 
Lymphatic Disease
The lymphatic circulation is grossly abnormal in the Fontan circulation. Lymphatic abnormalities result not only from increased lymphatic overproduction but also from obstruction (thoracic duct ligation), new lymphatic vessel formation, trauma and genetic abnormalities. The lymphatics have been implicated as being a critical part of the pathophysiology in plastic bronchitis, 136 in which there are abnormal communications between the bronchial lymphatics and the airways leading to lymphatic leakage into the small airways (Figure 8 ). Abnormal lymphatic channels communicating between the lymphatic drainage from the liver to the lumen of the small bowel has been demonstrated to be a key part of the pathophysiology of protein losing enteropathy. 137 Dynamic contrast MR lymphangiography has provided insight into the pathophysiology of pulmonary lymphatic flow discordance and provide guidance for transcatheter interventions.
Conclusions
The goals of diagnostic imaging in CHD are to identify anatomic and functional abnormalities, assess their severity, and provide information that informs clinical decisions. A rational multimodality approach individualized to each patient's clinical and safety profile is essential. Although the initial focus of imaging in CHD relates to diagnosis and repair, this changes as patients with CHD age. Residual structural heart disease, complications arising from surgical repair, and newly acquired disease (cardiac and extracardiac) are of increasing importance.
